English

THERASENSE INC

EDGAR

Annual report (10-K) · filed 2004-03-12

11 filing records in this dataset, filed from 2001-11-14 to 2004-03-12. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Insider filings have not been processed for this company yet.

See all insider transactions

Latest quarter

Revenue

61.8 million USD

2003-12-31 · USD

Exact inputs and evidence

Revenue: 211854000 USD Source
Revenue: 150064000 USD Source

Operating margin

7.39%

2003-12-31 · %

Exact inputs and evidence

Operating Income: -5314000 USD Source
Operating Income: -9878000 USD Source
Revenue: 211854000 USD Source
Revenue: 150064000 USD Source

Operating cash flow

6.61 million USD

2003-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 22411000 USD Source
Operating Cash Flow: 15801000 USD Source

Free cash flow

4.37 million USD

2003-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: 22411000 USD Source
Operating Cash Flow: 15801000 USD Source
Capital Expenditure: 8775000 USD Source
Capital Expenditure: 6536000 USD Source

Cash and cash equivalents: 43.3 million USD 2003-12-31 Source
Exact value

43301000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

212 million USD

2003-01-01 – 2003-12-31

Exact inputs and evidence

Revenue: 40904000 USD · 2003-01-01 – 2003-03-31 Source
Revenue: 50930000 USD · 2003-04-01 – 2003-06-30 Source
Revenue: 58230000 USD · 2003-07-01 – 2003-09-30 Source
Revenue: 211854000 USD · 2003-01-01 – 2003-12-31 Source
Revenue: 150064000 USD · 2003-01-01 – 2003-09-30 Source

Net income

-4.77 million USD

2003-01-01 – 2003-12-31

Exact inputs and evidence

Net income: -8539000 USD · 2003-01-01 – 2003-03-31 Source
Net income: -3476000 USD · 2003-04-01 – 2003-06-30 Source
Net income: 2690000 USD · 2003-07-01 – 2003-09-30 Source
Net income: -4774000 USD · 2003-01-01 – 2003-12-31 Source
Net income: -9325000 USD · 2003-01-01 – 2003-09-30 Source

Operating cash flow

22.4 million USD

2003-01-01 – 2003-12-31

Exact inputs and evidence

Operating cash flow: 4553000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: 10010000 USD · 2003-01-01 – 2003-06-30 Source
Operating cash flow: 4553000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: 15801000 USD · 2003-01-01 – 2003-09-30 Source
Operating cash flow: 10010000 USD · 2003-01-01 – 2003-06-30 Source
Operating cash flow: 22411000 USD · 2003-01-01 – 2003-12-31 Source
Operating cash flow: 15801000 USD · 2003-01-01 – 2003-09-30 Source

Capital expenditure

8.78 million USD

2003-01-01 – 2003-12-31

Exact inputs and evidence

Capital expenditure: 2387000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 4766000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 2387000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 6536000 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 4766000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 8775000 USD · 2003-01-01 – 2003-12-31 Source
Capital expenditure: 6536000 USD · 2003-01-01 – 2003-09-30 Source

Free cash flow

13.6 million USD

2003-01-01 – 2003-12-31

Exact inputs and evidence

Operating cash flow: 4553000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: 10010000 USD · 2003-01-01 – 2003-06-30 Source
Operating cash flow: 4553000 USD · 2003-01-01 – 2003-03-31 Source
Operating cash flow: 15801000 USD · 2003-01-01 – 2003-09-30 Source
Operating cash flow: 10010000 USD · 2003-01-01 – 2003-06-30 Source
Operating cash flow: 22411000 USD · 2003-01-01 – 2003-12-31 Source
Operating cash flow: 15801000 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 2387000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 4766000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 2387000 USD · 2003-01-01 – 2003-03-31 Source
Capital expenditure: 6536000 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 4766000 USD · 2003-01-01 – 2003-06-30 Source
Capital expenditure: 8775000 USD · 2003-01-01 – 2003-12-31 Source
Capital expenditure: 6536000 USD · 2003-01-01 – 2003-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2004-03-12.

Financial data available through: 2003-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2003-12-31
Operating income: 5 of 11 periods available· newest 2003-12-31
Net income: 5 of 11 periods available· newest 2003-12-31
Operating cash flow: 5 of 11 periods available· newest 2003-12-31
Capital expenditure: 5 of 11 periods available· newest 2003-12-31
Total assets: 4 of 11 periods available· newest 2003-12-31
Total liabilities: 4 of 11 periods available· newest 2003-12-31
Current assets: 4 of 11 periods available· newest 2003-12-31
Current liabilities: 4 of 11 periods available· newest 2003-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2003-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+19.2%

Prior period

USD 177.71 million

2002-01-01 – 2002-12-31
Current period

USD 211.85 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

211854000 − 177708000 = 34146000 USD

177708000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
211854000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · THERASENSE INC · 2003-12-31 THERASENSE INC (edgar:1073695) Year-over-year change in Revenue: 34146000 USD Concept: fundies:Revenue Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 211854000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#8553 Input fundies:Revenue: 177708000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#8553
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 24.39 million

Prior period

−USD 29.16 million

2002-01-01 – 2002-12-31
Current period

−USD 4.77 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

-4774000 − -29162000 = 24388000 USD

-29162000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
-4774000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · THERASENSE INC · 2003-12-31 THERASENSE INC (edgar:1073695) Year-over-year change in Net income: 24388000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4774000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10390 Input fundies:NetIncome: -29162000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10390
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 86.71 million

Prior period

−USD 64.3 million

2002-01-01 – 2002-12-31
Current period

USD 22.41 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

22411000 − -64299000 = 86710000 USD

-64299000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
22411000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · THERASENSE INC · 2003-12-31 THERASENSE INC (edgar:1073695) Year-over-year change in Operating cash flow: 86710000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 22411000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10642 Input fundies:OperatingCashFlow: -64299000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10642
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-20.2%

Prior period

USD 11 million

2002-01-01 – 2002-12-31
Current period

USD 8.78 million

2003-01-01 – 2003-12-31

Exact inputs and evidence

8775000 − 11000000 = -2225000 USD

11000000 USD · 2002-01-01 – 2002-12-31
Inspect prior input Prior source
8775000 USD · 2003-01-01 – 2003-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · THERASENSE INC · 2003-12-31 THERASENSE INC (edgar:1073695) Year-over-year change in Capital expenditure: -2225000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 8775000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10712 Input fundies:CapitalExpenditure: 11000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10712
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2003 2003-01-01 – 2003-12-31

Revenue USD 211.85 million 100% of revenue
Cost of revenue USD 88.14 million 42% of revenue
Operating expenses USD 129.03 million 61% of revenue
Operating income −USD 5.31 million −2.5% of revenue
Tax, interest and other Derived −USD 540,000 −0.3% of revenue
Net income −USD 4.77 million −2.3% of revenue

Cash

Operating cash flow USD 22.41 million 11% of revenue
Capital expenditure USD 8.78 million 4.1% of revenue
Free cash flow Derived USD 13.64 million 6.4% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Operating loss: operating costs were 15,510% of revenue.
2000 Operating loss: operating costs were 898% of revenue.
2001 Operating loss: operating costs were 175% of revenue.
2002 Operating loss: operating costs were 117% of revenue.
2003 Operating loss: operating costs were 103% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	85296	13229225 Derived	-13143929	-86207 Derived	-13057722	-15114817 Derived	Source 1999-01-01 – 1999-12-31: 85296 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -13143929 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -13057722 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -11791410 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 3323407 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	5503250	49427742 Derived	-43924492	-332655 Derived	-43591837	-38865936 Derived	Source 2000-01-01 – 2000-12-31: 5503250 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -43924492 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -43591837 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -36777342 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 2088594 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	71855000	125708000 Derived	-53853000	-987000 Derived	-52866000	-40272000 Derived	Source 2001-01-01 – 2001-12-31: 71855000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -53853000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -52866000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -36588000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 3684000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	177708000	207985000 Derived	-30277000	-1115000 Derived	-29162000	-75299000 Derived	Source 2002-01-01 – 2002-12-31: 177708000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -30277000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -29162000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -64299000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 11000000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	211854000	217168000 Derived	-5314000	-540000 Derived	-4774000	13636000 Derived	Source 2003-01-01 – 2003-12-31: 211854000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -5314000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -4774000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 22411000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 8775000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 211.9M 2003

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	85296	Revenue: 85296 Open source
20002000-12-31	Revenue	5503250	Revenue: 5503250 Open source
20012001-12-31	Revenue	71855000	Revenue: 71855000 Open source
20022002-12-31	Revenue	177708000	Revenue: 177708000 Open source
20032003-12-31	Revenue	211854000	Revenue: 211854000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

19.2% 2003

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	No prior comparable period	Revenue: 85296 Open source
20002000-12-31	Year over year	6,351.9%	Revenue: 5503250 Open source Revenue: 85296 Open source
20012001-12-31	Year over year	1,205.7%	Revenue: 71855000 Open source Revenue: 5503250 Open source
20022002-12-31	Year over year	147.3%	Revenue: 177708000 Open source Revenue: 71855000 Open source
20032003-12-31	Year over year	19.2%	Revenue: 211854000 Open source Revenue: 177708000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2.5% 2003

Net margin -2.3% 2003

Free cash flow margin 6.4% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Operating margin	-15,409.8%	Operating Income: -13143929 Open source Revenue: 85296 Open source
20002000-12-31	Operating margin	-798.2%	Operating Income: -43924492 Open source Revenue: 5503250 Open source
20012001-12-31	Operating margin	-74.9%	Operating Income: -53853000 Open source Revenue: 71855000 Open source
20022002-12-31	Operating margin	-17%	Operating Income: -30277000 Open source Revenue: 177708000 Open source
20032003-12-31	Operating margin	-2.5%	Operating Income: -5314000 Open source Revenue: 211854000 Open source
19991999-12-31	Net margin	-15,308.7%	Net Income: -13057722 Open source Revenue: 85296 Open source
20002000-12-31	Net margin	-792.1%	Net Income: -43591837 Open source Revenue: 5503250 Open source
20012001-12-31	Net margin	-73.6%	Net Income: -52866000 Open source Revenue: 71855000 Open source
20022002-12-31	Net margin	-16.4%	Net Income: -29162000 Open source Revenue: 177708000 Open source
20032003-12-31	Net margin	-2.3%	Net Income: -4774000 Open source Revenue: 211854000 Open source
19991999-12-31	Free cash flow margin	-17,720.4%	Revenue: 85296 Open source Operating Cash Flow: -11791410 Open source Capital Expenditure: 3323407 Open source
20002000-12-31	Free cash flow margin	-706.2%	Revenue: 5503250 Open source Operating Cash Flow: -36777342 Open source Capital Expenditure: 2088594 Open source
20012001-12-31	Free cash flow margin	-56%	Revenue: 71855000 Open source Operating Cash Flow: -36588000 Open source Capital Expenditure: 3684000 Open source
20022002-12-31	Free cash flow margin	-42.4%	Revenue: 177708000 Open source Operating Cash Flow: -64299000 Open source Capital Expenditure: 11000000 Open source
20032003-12-31	Free cash flow margin	6.4%	Revenue: 211854000 Open source Operating Cash Flow: 22411000 Open source Capital Expenditure: 8775000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 22.4M 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	-11791410	Operating Cash Flow: -11791410 Open source
20002000-12-31	Operating cash flow	-36777342	Operating Cash Flow: -36777342 Open source
20012001-12-31	Operating cash flow	-36588000	Operating Cash Flow: -36588000 Open source
20022002-12-31	Operating cash flow	-64299000	Operating Cash Flow: -64299000 Open source
20032003-12-31	Operating cash flow	22411000	Operating Cash Flow: 22411000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 13.6M 2003

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	-15114817	Operating Cash Flow: -11791410 Open source Capital Expenditure: 3323407 Open source
20002000-12-31	Free cash flow	-38865936	Operating Cash Flow: -36777342 Open source Capital Expenditure: 2088594 Open source
20012001-12-31	Free cash flow	-40272000	Operating Cash Flow: -36588000 Open source Capital Expenditure: 3684000 Open source
20022002-12-31	Free cash flow	-75299000	Operating Cash Flow: -64299000 Open source Capital Expenditure: 11000000 Open source
20032003-12-31	Free cash flow	13636000	Operating Cash Flow: 22411000 Open source Capital Expenditure: 8775000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

26.3% 2003

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Liabilities / assets	Not reported	No source recorded
20002000-12-31	Liabilities / assets	91.9%	Total Liabilities: 34530627 Open source Total Assets: 37564915 Open source
20012001-12-31	Liabilities / assets	35.4%	Total Liabilities: 73036967 Open source Total Assets: 206575970 Open source
20022002-12-31	Liabilities / assets	28.1%	Total Liabilities: 45214000 Open source Total Assets: 160803000 Open source
20032003-12-31	Liabilities / assets	26.3%	Total Liabilities: 43259000 Open source Total Assets: 164443000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.94× 2003

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1999-12-31	Current assets / current liabilities	Not reported	No source recorded
20002000-12-31	Current assets / current liabilities	1.16×	Current Assets: 30775930 Open source Current Liabilities: 26536142 Open source
20012001-12-31	Current assets / current liabilities	2.99×	Current Assets: 192929074 Open source Current Liabilities: 64520819 Open source
20022002-12-31	Current assets / current liabilities	3.31×	Current Assets: 130030000 Open source Current Liabilities: 39293000 Open source
20032003-12-31	Current assets / current liabilities	3.94×	Current Assets: 123963000 Open source Current Liabilities: 31439000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	−USD 13.06 million Exact value Exact value: -13057722 USD 1999-01-01 – 1999-12-31: -13057722 USD Inspect Net Income Open source Share or cite Citation for Net Income · THERASENSE INC · 1999-12-31 THERASENSE INC (edgar:1073695) Net Income: -13057722 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13057722 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001012870-02-001322.txt#3584 The citation records this snapshot. The page link may show a newer release later.	−USD 11.79 million Exact value Exact value: -11791410 USD 1999-01-01 – 1999-12-31: -11791410 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · THERASENSE INC · 1999-12-31 THERASENSE INC (edgar:1073695) Operating Cash Flow: -11791410 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11791410 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001012870-02-001322.txt#3601 The citation records this snapshot. The page link may show a newer release later.	USD 3.32 million Exact value Exact value: 3323407 USD 1999-01-01 – 1999-12-31: 3323407 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · THERASENSE INC · 1999-12-31 THERASENSE INC (edgar:1073695) Capital Expenditure: 3323407 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3323407 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001012870-02-001322.txt#3605 The citation records this snapshot. The page link may show a newer release later.	−USD 15.11 million Calculation and evidence -11791410 − 3323407 USD Exact free cash flow: -15114817 USD 1999-01-01 – 1999-12-31: -11791410 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 3323407 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · THERASENSE INC · 1999-12-31 THERASENSE INC (edgar:1073695) Free cash flow: -15114817 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11791410 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001012870-02-001322.txt#3601 Input fundies:CapitalExpenditure: 3323407 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001012870-02-001322.txt#3605 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 43.59 million Exact value Exact value: -43591837 USD 2000-01-01 – 2000-12-31: -43591837 USD Inspect Net Income Open source Share or cite Citation for Net Income · THERASENSE INC · 2000-12-31 THERASENSE INC (edgar:1073695) Net Income: -43591837 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43591837 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0000950109-03-001718.txt#7393 The citation records this snapshot. The page link may show a newer release later.	−USD 36.78 million Exact value Exact value: -36777342 USD 2000-01-01 – 2000-12-31: -36777342 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · THERASENSE INC · 2000-12-31 THERASENSE INC (edgar:1073695) Operating Cash Flow: -36777342 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36777342 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0000950109-03-001718.txt#7646 The citation records this snapshot. The page link may show a newer release later.	USD 2.09 million Exact value Exact value: 2088594 USD 2000-01-01 – 2000-12-31: 2088594 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · THERASENSE INC · 2000-12-31 THERASENSE INC (edgar:1073695) Capital Expenditure: 2088594 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2088594 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0000950109-03-001718.txt#7716 The citation records this snapshot. The page link may show a newer release later.	−USD 38.87 million Calculation and evidence -36777342 − 2088594 USD Exact free cash flow: -38865936 USD 2000-01-01 – 2000-12-31: -36777342 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 2088594 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · THERASENSE INC · 2000-12-31 THERASENSE INC (edgar:1073695) Free cash flow: -38865936 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36777342 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0000950109-03-001718.txt#7646 Input fundies:CapitalExpenditure: 2088594 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0000950109-03-001718.txt#7716 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 52.87 million Exact value Exact value: -52866000 USD 2001-01-01 – 2001-12-31: -52866000 USD Inspect Net Income Open source Share or cite Citation for Net Income · THERASENSE INC · 2001-12-31 THERASENSE INC (edgar:1073695) Net Income: -52866000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -52866000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10390 The citation records this snapshot. The page link may show a newer release later.	−USD 36.59 million Exact value Exact value: -36588000 USD 2001-01-01 – 2001-12-31: -36588000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · THERASENSE INC · 2001-12-31 THERASENSE INC (edgar:1073695) Operating Cash Flow: -36588000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36588000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10642 The citation records this snapshot. The page link may show a newer release later.	USD 3.68 million Exact value Exact value: 3684000 USD 2001-01-01 – 2001-12-31: 3684000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · THERASENSE INC · 2001-12-31 THERASENSE INC (edgar:1073695) Capital Expenditure: 3684000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3684000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10712 The citation records this snapshot. The page link may show a newer release later.	−USD 40.27 million Calculation and evidence -36588000 − 3684000 USD Exact free cash flow: -40272000 USD 2001-01-01 – 2001-12-31: -36588000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 3684000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · THERASENSE INC · 2001-12-31 THERASENSE INC (edgar:1073695) Free cash flow: -40272000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36588000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10642 Input fundies:CapitalExpenditure: 3684000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10712 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 29.16 million Exact value Exact value: -29162000 USD 2002-01-01 – 2002-12-31: -29162000 USD Inspect Net Income Open source Share or cite Citation for Net Income · THERASENSE INC · 2002-12-31 THERASENSE INC (edgar:1073695) Net Income: -29162000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29162000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10390 The citation records this snapshot. The page link may show a newer release later.	−USD 64.3 million Exact value Exact value: -64299000 USD 2002-01-01 – 2002-12-31: -64299000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · THERASENSE INC · 2002-12-31 THERASENSE INC (edgar:1073695) Operating Cash Flow: -64299000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64299000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10642 The citation records this snapshot. The page link may show a newer release later.	USD 11 million Exact value Exact value: 11000000 USD 2002-01-01 – 2002-12-31: 11000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · THERASENSE INC · 2002-12-31 THERASENSE INC (edgar:1073695) Capital Expenditure: 11000000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10712 The citation records this snapshot. The page link may show a newer release later.	−USD 75.3 million Calculation and evidence -64299000 − 11000000 USD Exact free cash flow: -75299000 USD 2002-01-01 – 2002-12-31: -64299000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 11000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · THERASENSE INC · 2002-12-31 THERASENSE INC (edgar:1073695) Free cash flow: -75299000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -64299000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10642 Input fundies:CapitalExpenditure: 11000000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10712 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 4.77 million Exact value Exact value: -4774000 USD 2003-01-01 – 2003-12-31: -4774000 USD Inspect Net Income Open source Share or cite Citation for Net Income · THERASENSE INC · 2003-12-31 THERASENSE INC (edgar:1073695) Net Income: -4774000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4774000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10390 The citation records this snapshot. The page link may show a newer release later.	USD 22.41 million Exact value Exact value: 22411000 USD 2003-01-01 – 2003-12-31: 22411000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · THERASENSE INC · 2003-12-31 THERASENSE INC (edgar:1073695) Operating Cash Flow: 22411000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 22411000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10642 The citation records this snapshot. The page link may show a newer release later.	USD 8.78 million Exact value Exact value: 8775000 USD 2003-01-01 – 2003-12-31: 8775000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · THERASENSE INC · 2003-12-31 THERASENSE INC (edgar:1073695) Capital Expenditure: 8775000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8775000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10712 The citation records this snapshot. The page link may show a newer release later.	USD 13.64 million Calculation and evidence 22411000 − 8775000 USD Exact free cash flow: 13636000 USD 2003-01-01 – 2003-12-31: 22411000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 8775000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · THERASENSE INC · 2003-12-31 THERASENSE INC (edgar:1073695) Free cash flow: 13636000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-14T20:13:05Z Snapshot: 46ff8b5e8ae00a5596c5abc90718a74b991fb8965e99f4bcec2fde3d8bf7fc08 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1073695?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 22411000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10642 Input fundies:CapitalExpenditure: 8775000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1073695/0001193125-04-039438.txt#10712 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

11 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-14. Source filing dates and reporting periods are shown separately.

Identifiers: 0001073695, 1073695, edgar:1073695

THERASENSE INC

Holdings and insider activity

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2003 2003-01-01 – 2003-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation